iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionAdviser Investments LLC
Latest Disclosed Ownership4,289 shares
Latest Disclosed Value $ 724,130
Adviser Investments LLC reports 11.20% decrease in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 13, 2026 - Adviser Investments LLC filed a 13F-HR form disclosing ownership of 4,289 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $724,130 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 4,830 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of -11.20% during the quarter. The current value of the position is $562,073 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 4,289 -541 -11.20 724 -11.17 0.0079
2026-02-12 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 4,830 -13 -0.27 815 16.60 0.0089
2025-11-10 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 4,843 -886 -15.47 699 -3.45 0.0079
2025-08-06 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 5,729 -2,773 -32.62 725 -33.39 0.0091
2025-05-13 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 8,502 -2,787 -24.69 1,087 -27.14 0.0137
2025-02-12 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 11,289 -745 -6.19 1,493 -14.84 0.0184
2024-11-08 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 12,034 -829 -6.44 1,752 -0.74 0.0219
2024-08-12 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 12,863 -864 -6.29 1,766 -6.27 0.0233
2024-04-29 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 13,727 -5 -0.04 1,884 0.97 0.0253
2024-02-01 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 13,732 -560 -3.92 1,865 6.75 0.0266
2023-10-11 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 14,292 -3,092 -17.79 1,748 -20.84 0.0381
2023-08-04 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 17,384 -1,273 -6.82 2,207 -8.39 0.0483
2023-04-26 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 18,657 -785 -4.04 2,410 -7.52 0.0578
2023-01-19 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 19,442 -21,348 -52.34 2,605 -45.40 0.0648
2022-10-14 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 40,790 -952 -2.28 4,771 -2.83 0.3360
2022-07-14 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 41,742 16,630 66.22 4,910 50.06 0.3314
2022-05-04 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 25,112 37 0.15 3,272 -14.50 0.2118
2022-01-31 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 25,075 8,962 55.62 3,827 46.91 0.2569
2021-11-05 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 16,113 -6 -0.04 2,605 -1.25 0.1944
2021-07-09 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 16,119 440 2.81 2,638 11.73 0.1968
2021-05-05 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 15,679 -37,418 -70.47 2,361 -70.65 0.1905
2021-01-26 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 53,097 33,668 173.29 8,044 205.74 0.7135
2020-11-13 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 19,429 -45,316 -69.99 2,631 -70.27 0.2768
2020-08-03 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 64,745 44,945 226.99 8,850 314.91 1.0819
2020-04-08 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 19,800 -796 -3.86 2,133 -14.06 0.3023
2020-02-07 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 20,596 357 1.76 2,482 23.24 0.2461
2019-11-13 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 20,239 -304 -1.48 2,014 -10.13 0.2127
2019-08-12 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 20,543 525 2.62 2,241 0.13 0.2406
2019-05-07 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 20,018 -243 -1.20 2,238 14.53 0.2558
2019-01-25 2018-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 20,261 779 4.00 1,954 -17.76 0.2570
2018-11-13 2018-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 19,482 3,500 21.90 2,376 35.38 0.2660
2018-08-02 2018-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 15,982 421 2.71 1,755 5.66 0.1958
2018-05-14 2018-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 15,561 1,432 10.14 1,661 10.07 0.2136
2018-02-12 2017-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 14,129 -6,648 -32.00 1,509 -78.23 0.1696
2017-10-23 2017-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 20,777 20,777 6,931 0.7819
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.